Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 58 entries
Sorted by: Best Match Show Resources per page
Finding the Missing Millions: Can a New Questionnaire Help to Detect Undiagnosed Chronic Obstructive Pulmonary Disease?.

American journal of respiratory and critical care medicine

van der Molen T, Kocks JW, Tsiligianni IG.
PMID: 28294653
Am J Respir Crit Care Med. 2017 Mar 15;195(6):708-710. doi: 10.1164/rccm.201610-2146ED.

No abstract available.

Cite
van der Molen T, Kocks JW, Tsiligianni IG. Finding the Missing Millions: Can a New Questionnaire Help to Detect Undiagnosed Chronic Obstructive Pulmonary Disease?. Am J Respir Crit Care Med. 2017;195(6):708-710doi: 10.1164/rccm.201610-2146ED.
van der Molen, T., Kocks, J. W., & Tsiligianni, I. G. (2017). Finding the Missing Millions: Can a New Questionnaire Help to Detect Undiagnosed Chronic Obstructive Pulmonary Disease?. American journal of respiratory and critical care medicine, 195(6), 708-710. https://doi.org/10.1164/rccm.201610-2146ED
van der Molen, Thys, et al. "Finding the Missing Millions: Can a New Questionnaire Help to Detect Undiagnosed Chronic Obstructive Pulmonary Disease?." American journal of respiratory and critical care medicine vol. 195,6 (2017): 708-710. doi: https://doi.org/10.1164/rccm.201610-2146ED
van der Molen T, Kocks JW, Tsiligianni IG. Finding the Missing Millions: Can a New Questionnaire Help to Detect Undiagnosed Chronic Obstructive Pulmonary Disease?. Am J Respir Crit Care Med. 2017 Mar 15;195(6):708-710. doi: 10.1164/rccm.201610-2146ED. PMID: 28294653.
Copy Download .nbib Format: NLM
Pulmonary function in children with idiopathic scoliosis.

Scoliosis

Tsiligiannis T, Grivas T.
PMID: 22445133
Scoliosis. 2012 Mar 23;7(1):7. doi: 10.1186/1748-7161-7-7.

Idiopathic scoliosis, a common disorder of lateral displacement and rotation of vertebral bodies during periods of rapid somatic growth, has many effects on respiratory function. Scoliosis results in a restrictive lung disease with a multifactorial decrease in lung volumes,...

Cite
Tsiligiannis T, Grivas T. Pulmonary function in children with idiopathic scoliosis. Scoliosis. 2012;7(1):7doi: 10.1186/1748-7161-7-7.
Tsiligiannis, T., & Grivas, T. (2012). Pulmonary function in children with idiopathic scoliosis. Scoliosis, 7(1), 7. https://doi.org/10.1186/1748-7161-7-7
Tsiligiannis, Theofanis, and Grivas, Theodoros. "Pulmonary function in children with idiopathic scoliosis." Scoliosis vol. 7,1 (2012): 7. doi: https://doi.org/10.1186/1748-7161-7-7
Tsiligiannis T, Grivas T. Pulmonary function in children with idiopathic scoliosis. Scoliosis. 2012 Mar 23;7(1):7. doi: 10.1186/1748-7161-7-7. PMID: 22445133; PMCID: PMC3410782.
Copy Download .nbib Format: NLM
Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations.

Primary care respiratory journal : journal of the General Practice Airways Group

Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T.
PMID: 21472192
Prim Care Respir J. 2011 Sep;20(3):257-68. doi: 10.4104/pcrj.2011.00029.

BACKGROUND: A major goal in the management of chronic obstructive pulmonary disease (COPD) is to ensure that the burden of the disease for patients with COPD is limited and that patients will have the best possible quality of life.AIMS:...

Cite
Tsiligianni I, Kocks J, Tzanakis N, et al. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011;20(3):257-68doi: 10.4104/pcrj.2011.00029.
Tsiligianni, I., Kocks, J., Tzanakis, N., Siafakas, N., & van der Molen, T. (2011). Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Primary care respiratory journal : journal of the General Practice Airways Group, 20(3), 257-68. https://doi.org/10.4104/pcrj.2011.00029
Tsiligianni, Ioanna, et al. "Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations." Primary care respiratory journal : journal of the General Practice Airways Group vol. 20,3 (2011): 257-68. doi: https://doi.org/10.4104/pcrj.2011.00029
Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011 Sep;20(3):257-68. doi: 10.4104/pcrj.2011.00029. PMID: 21472192; PMCID: PMC6549844.
Copy Download .nbib Format: NLM
ERS Presidential Summit 2018: multimorbidities and the ageing population.

ERJ open research

Gaga M, Powell P, Almagro M, Tsiligianni I, Loukides S, Roca J, Cullen M, Simonds AK, Ward B, Saraiva I, Troosters T, Robalo Cordeiro C.
PMID: 31579675
ERJ Open Res. 2019 Sep 25;5(3). doi: 10.1183/23120541.00126-2019. eCollection 2019 Jul.

As the average age of the population increases, so will the prevalence of chronic respiratory diseases and associated multimorbidity. This will result in a more complex clinical environment. Part of the solution will be to allow patients to be...

Cite
Gaga M, Powell P, Almagro M, et al. ERS Presidential Summit 2018: multimorbidities and the ageing population. ERJ Open Res. 2019;5(3)doi: 10.1183/23120541.00126-2019.
Gaga, M., Powell, P., Almagro, M., Tsiligianni, I., Loukides, S., Roca, J., Cullen, M., Simonds, A. K., Ward, B., Saraiva, I., Troosters, T., & Robalo Cordeiro, C. (2019). ERS Presidential Summit 2018: multimorbidities and the ageing population. ERJ open research, 5(3), . https://doi.org/10.1183/23120541.00126-2019
Gaga, Mina, et al. "ERS Presidential Summit 2018: multimorbidities and the ageing population." ERJ open research vol. 5,3 (2019). doi: https://doi.org/10.1183/23120541.00126-2019
Gaga M, Powell P, Almagro M, Tsiligianni I, Loukides S, Roca J, Cullen M, Simonds AK, Ward B, Saraiva I, Troosters T, Robalo Cordeiro C. ERS Presidential Summit 2018: multimorbidities and the ageing population. ERJ Open Res. 2019 Sep 25;5(3). doi: 10.1183/23120541.00126-2019. eCollection 2019 Jul. PMID: 31579675; PMCID: PMC6759575.
Copy Download .nbib Format: NLM
Evaluation of Obstructive Sleep Apnea in Female Patients in Primary Care: Time for Improvement?.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre

Bouloukaki I, Tsiligianni I, Schiza S.
PMID: 34438402
Med Princ Pract. 2021;30(6):508-514. doi: 10.1159/000518932. Epub 2021 Aug 26.

Obstructive sleep apnea (OSA) has historically been regarded as a male disease. However, there are a number of significant gender-related differences in the symptoms, diagnosis, and consequences of OSA, which seems to be more severe in male than in...

Cite
Bouloukaki I, Tsiligianni I, Schiza S. Evaluation of Obstructive Sleep Apnea in Female Patients in Primary Care: Time for Improvement?. Med Princ Pract. 2021;30(6):508-514doi: 10.1159/000518932.
Bouloukaki, I., Tsiligianni, I., & Schiza, S. (2021). Evaluation of Obstructive Sleep Apnea in Female Patients in Primary Care: Time for Improvement?. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 30(6), 508-514. https://doi.org/10.1159/000518932
Bouloukaki, Izolde, et al. "Evaluation of Obstructive Sleep Apnea in Female Patients in Primary Care: Time for Improvement?." Medical principles and practice : international journal of the Kuwait University, Health Science Centre vol. 30,6 (2021): 508-514. doi: https://doi.org/10.1159/000518932
Bouloukaki I, Tsiligianni I, Schiza S. Evaluation of Obstructive Sleep Apnea in Female Patients in Primary Care: Time for Improvement?. Med Princ Pract. 2021;30(6):508-514. doi: 10.1159/000518932. Epub 2021 Aug 26. PMID: 34438402.
Copy Download .nbib Format: NLM
Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?.

Journal of clinical medicine

Tsilogianni Z, Baker JR, Papaporfyriou A, Papaioannou AI, Papathanasiou E, Koulouris NG, Daly L, Ito K, Hillas G, Papiris S, Bakakos P, Loukides S.
PMID: 32050426
J Clin Med. 2020 Feb 09;9(2). doi: 10.3390/jcm9020473.

BACKGROUND: Sestrin 2, Endocan, and Sirtuin 1 are distinct molecules with some biologic actions associated with asthma pathophysiology. The aim of the present study was to determine the molecular level differences attributable to underlying asthma severity.METHODS: We initially recruited...

Cite
Tsilogianni Z, Baker JR, Papaporfyriou A, et al. Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?. J Clin Med. 2020;9(2)doi: 10.3390/jcm9020473.
Tsilogianni, Z., Baker, J. R., Papaporfyriou, A., Papaioannou, A. I., Papathanasiou, E., Koulouris, N. G., Daly, L., Ito, K., Hillas, G., Papiris, S., Bakakos, P., & Loukides, S. (2020). Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?. Journal of clinical medicine, 9(2), . https://doi.org/10.3390/jcm9020473
Tsilogianni, Zoe, et al. "Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?." Journal of clinical medicine vol. 9,2 (2020). doi: https://doi.org/10.3390/jcm9020473
Tsilogianni Z, Baker JR, Papaporfyriou A, Papaioannou AI, Papathanasiou E, Koulouris NG, Daly L, Ito K, Hillas G, Papiris S, Bakakos P, Loukides S. Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?. J Clin Med. 2020 Feb 09;9(2). doi: 10.3390/jcm9020473. PMID: 32050426; PMCID: PMC7073772.
Copy Download .nbib Format: NLM
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).

Journal of thoracic disease

Bousquet J, Pham-Thi N, Bedbrook A, Agache I, Annesi-Maesano I, Ansotegui I, Anto JM, Bachert C, Benveniste S, Bewick M, Billo N, Bosnic-Anticevich S, Bosse I, Brusselle G, Calderon MA, Canonica GW, Caraballo L, Cardona V, Carriazo AM, Cash E, Cecchi L, Chu DK, Colgan E, Costa E, Cruz AA, Czarlewski W, Durham S, Ebisawa M, Erhola M, Fauquert JL, Fokkens WJ, Fonseca JA, Guldemond N, Iinuma T, Illario M, Klimek L, Kuna P, Kvedariene V, Larenas-Linneman D, Laune D, Le LTT, Lourenço O, Malva JO, Marien G, Menditto E, Mullol J, Münter L, Okamoto Y, Onorato GL, Papadopoulos NG, Perala M, Pfaar O, Phillips A, Phillips J, Pinnock H, Portejoie F, Quinones-Delgado P, Rolland C, Rodts U, Samolinski B, Sanchez-Borges M, Schünemann HJ, Shamji M, Somekh D, Togias A, Toppila-Salmi S, Tsiligianni I, Usmani O, Walker S, Wallace D, Valiulis A, Van der Kleij R, Ventura MT, Williams S, Yorgancioglu A, Zuberbier T.
PMID: 31559071
J Thorac Dis. 2019 Aug;11(8):3633-3642. doi: 10.21037/jtd.2019.08.64.

No abstract available.

Cite
Bousquet J, Pham-Thi N, Bedbrook A, et al. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1). J Thorac Dis. 2019;11(8):3633-3642doi: 10.21037/jtd.2019.08.64.
Bousquet, J., Pham-Thi, N., Bedbrook, A., Agache, I., Annesi-Maesano, I., Ansotegui, I., Anto, J. M., Bachert, C., Benveniste, S., Bewick, M., Billo, N., Bosnic-Anticevich, S., Bosse, I., Brusselle, G., Calderon, M. A., Canonica, G. W., Caraballo, L., Cardona, V., Carriazo, A. M., Cash, E., Cecchi, L., Chu, D. K., Colgan, E., Costa, E., Cruz, A. A., Czarlewski, W., Durham, S., Ebisawa, M., Erhola, M., Fauquert, J. L., Fokkens, W. J., Fonseca, J. A., Guldemond, N., Iinuma, T., Illario, M., Klimek, L., Kuna, P., Kvedariene, V., Larenas-Linneman, D., Laune, D., Le, L. T. T., Lourenço, O., Malva, J. O., Marien, G., Menditto, E., Mullol, J., Münter, L., Okamoto, Y., Onorato, G. L., Papadopoulos, N. G., Perala, M., Pfaar, O., Phillips, A., Phillips, J., Pinnock, H., Portejoie, F., Quinones-Delgado, P., Rolland, C., Rodts, U., Samolinski, B., Sanchez-Borges, M., Schünemann, H. J., Shamji, M., Somekh, D., Togias, A., Toppila-Salmi, S., Tsiligianni, I., Usmani, O., Walker, S., Wallace, D., Valiulis, A., Van der Kleij, R., Ventura, M. T., Williams, S., Yorgancioglu, A., & Zuberbier, T. (2019). Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1). Journal of thoracic disease, 11(8), 3633-3642. https://doi.org/10.21037/jtd.2019.08.64
Bousquet, Jean, et al. "Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1)." Journal of thoracic disease vol. 11,8 (2019): 3633-3642. doi: https://doi.org/10.21037/jtd.2019.08.64
Bousquet J, Pham-Thi N, Bedbrook A, Agache I, Annesi-Maesano I, Ansotegui I, Anto JM, Bachert C, Benveniste S, Bewick M, Billo N, Bosnic-Anticevich S, Bosse I, Brusselle G, Calderon MA, Canonica GW, Caraballo L, Cardona V, Carriazo AM, Cash E, Cecchi L, Chu DK, Colgan E, Costa E, Cruz AA, Czarlewski W, Durham S, Ebisawa M, Erhola M, Fauquert JL, Fokkens WJ, Fonseca JA, Guldemond N, Iinuma T, Illario M, Klimek L, Kuna P, Kvedariene V, Larenas-Linneman D, Laune D, Le LTT, Lourenço O, Malva JO, Marien G, Menditto E, Mullol J, Münter L, Okamoto Y, Onorato GL, Papadopoulos NG, Perala M, Pfaar O, Phillips A, Phillips J, Pinnock H, Portejoie F, Quinones-Delgado P, Rolland C, Rodts U, Samolinski B, Sanchez-Borges M, Schünemann HJ, Shamji M, Somekh D, Togias A, Toppila-Salmi S, Tsiligianni I, Usmani O, Walker S, Wallace D, Valiulis A, Van der Kleij R, Ventura MT, Williams S, Yorgancioglu A, Zuberbier T. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1). J Thorac Dis. 2019 Aug;11(8):3633-3642. doi: 10.21037/jtd.2019.08.64. PMID: 31559071; PMCID: PMC6753463.
Copy Download .nbib Format: NLM
Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak.

The Lancet regional health. Europe

Kardas P, van Boven JFM, Pinnock H, Menditto E, Wettermark B, Tsiligianni I, Ágh T.
PMID: 33875981
Lancet Reg Health Eur. 2021 May;4:100099. doi: 10.1016/j.lanepe.2021.100099. Epub 2021 Apr 14.

No abstract available.

Cite
Kardas P, van Boven JFM, Pinnock H, et al. Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak. Lancet Reg Health Eur. 2021;4:100099doi: 10.1016/j.lanepe.2021.100099.
Kardas, P., van Boven, J. F. M., Pinnock, H., Menditto, E., Wettermark, B., Tsiligianni, I., Ágh, T. (2021). Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak. The Lancet regional health. Europe, 4100099. https://doi.org/10.1016/j.lanepe.2021.100099
Kardas, Przemyslaw, et al. "Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak." The Lancet regional health. Europe vol. 4 (2021): 100099. doi: https://doi.org/10.1016/j.lanepe.2021.100099
Kardas P, van Boven JFM, Pinnock H, Menditto E, Wettermark B, Tsiligianni I, Ágh T. Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak. Lancet Reg Health Eur. 2021 May;4:100099. doi: 10.1016/j.lanepe.2021.100099. Epub 2021 Apr 14. PMID: 33875981; PMCID: PMC8046426.
Copy Download .nbib Format: NLM
European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement.

Frontiers in pharmacology

van Boven JF, Tsiligianni I, Potočnjak I, Mihajlović J, Dima AL, Nabergoj Makovec U, Ágh T, Kardas P, Ghiciuc CM, Petrova G, Bitterman N, Kamberi F, Culig J, Wettermark B.
PMID: 34707502
Front Pharmacol. 2021 Oct 11;12:748702. doi: 10.3389/fphar.2021.748702. eCollection 2021.

Medication non-adherence is associated with almost 200,000 deaths annually and €80-125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence....

Cite
van Boven JF, Tsiligianni I, Potočnjak I, et al. European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement. Front Pharmacol. 2021;12:748702doi: 10.3389/fphar.2021.748702.
van Boven, J. F., Tsiligianni, I., Potočnjak, I., Mihajlović, J., Dima, A. L., Nabergoj Makovec, U., Ágh, T., Kardas, P., Ghiciuc, C. M., Petrova, G., Bitterman, N., Kamberi, F., Culig, J., & Wettermark, B. (2021). European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement. Frontiers in pharmacology, 12748702. https://doi.org/10.3389/fphar.2021.748702
van Boven, Job Fm, et al. "European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement." Frontiers in pharmacology vol. 12 (2021): 748702. doi: https://doi.org/10.3389/fphar.2021.748702
van Boven JF, Tsiligianni I, Potočnjak I, Mihajlović J, Dima AL, Nabergoj Makovec U, Ágh T, Kardas P, Ghiciuc CM, Petrova G, Bitterman N, Kamberi F, Culig J, Wettermark B. European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement. Front Pharmacol. 2021 Oct 11;12:748702. doi: 10.3389/fphar.2021.748702. eCollection 2021. PMID: 34707502; PMCID: PMC8544003.
Copy Download .nbib Format: NLM
Sputum interleukin-13 as a biomarker for the evaluation of asthma control.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Tsilogianni Z, Hillas G, Bakakos P, Aggelakis L, Konstantellou E, Papaioannou AI, Papaporfyriou A, Papiris S, Koulouris N, Loukides S, Kostikas K.
PMID: 27790845
Clin Exp Allergy. 2016 Nov;46(11):1498. doi: 10.1111/cea.12825.

No abstract available.

Cite
Tsilogianni Z, Hillas G, Bakakos P, et al. Sputum interleukin-13 as a biomarker for the evaluation of asthma control. Clin Exp Allergy. 2016;46(11):1498doi: 10.1111/cea.12825.
Tsilogianni, Z., Hillas, G., Bakakos, P., Aggelakis, L., Konstantellou, E., Papaioannou, A. I., Papaporfyriou, A., Papiris, S., Koulouris, N., Loukides, S., & Kostikas, K. (2016). Sputum interleukin-13 as a biomarker for the evaluation of asthma control. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 46(11), 1498. https://doi.org/10.1111/cea.12825
Tsilogianni, Z, et al. "Sputum interleukin-13 as a biomarker for the evaluation of asthma control." Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology vol. 46,11 (2016): 1498. doi: https://doi.org/10.1111/cea.12825
Tsilogianni Z, Hillas G, Bakakos P, Aggelakis L, Konstantellou E, Papaioannou AI, Papaporfyriou A, Papiris S, Koulouris N, Loukides S, Kostikas K. Sputum interleukin-13 as a biomarker for the evaluation of asthma control. Clin Exp Allergy. 2016 Nov;46(11):1498. doi: 10.1111/cea.12825. PMID: 27790845.
Copy Download .nbib Format: NLM
Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report.

Journal of thoracic disease

Bousquet J, Bedbrook A, Czarlewski W, De Carlo G, Fonseca JA, González Ballester MA, Illario M, Koskinen S, Laatikainen T, Onorato GL, Palkonen S, Patella V, Pham-Thi N, Puggioni F, Ventura MT, Joos G, Kuna P, Louis R, Makris M, Zalud P, Zuberbier T, Bachert C, Brussino L, Carreiro-Martins P, Carrion Y Ribas C, Chalubinski M, Costa EM, de Vries G, Gemicioglu B, Gennimata D, Micheli Y, Niedoszytko M, Regateiro FS, Romantowski J, Taborda-Barata L, Toppila-Salmi S, Tsiligianni I, Viart F, Laune D.
PMID: 34164213
J Thorac Dis. 2021 May;13(5):3215-3225. doi: 10.21037/jtd-21-792.

No abstract available.

Cite
Bousquet J, Bedbrook A, Czarlewski W, et al. Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report. J Thorac Dis. 2021;13(5):3215-3225doi: 10.21037/jtd-21-792.
Bousquet, J., Bedbrook, A., Czarlewski, W., De Carlo, G., Fonseca, J. A., González Ballester, M. A., Illario, M., Koskinen, S., Laatikainen, T., Onorato, G. L., Palkonen, S., Patella, V., Pham-Thi, N., Puggioni, F., Ventura, M. T., Joos, G., Kuna, P., Louis, R., Makris, M., Zalud, P., Zuberbier, T., Bachert, C., Brussino, L., Carreiro-Martins, P., Carrion Y Ribas, C., Chalubinski, M., Costa, E. M., de Vries, G., Gemicioglu, B., Gennimata, D., Micheli, Y., Niedoszytko, M., Regateiro, F. S., Romantowski, J., Taborda-Barata, L., Toppila-Salmi, S., Tsiligianni, I., Viart, F., & Laune, D. (2021). Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report. Journal of thoracic disease, 13(5), 3215-3225. https://doi.org/10.21037/jtd-21-792
Bousquet, Jean, et al. "Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report." Journal of thoracic disease vol. 13,5 (2021): 3215-3225. doi: https://doi.org/10.21037/jtd-21-792
Bousquet J, Bedbrook A, Czarlewski W, De Carlo G, Fonseca JA, González Ballester MA, Illario M, Koskinen S, Laatikainen T, Onorato GL, Palkonen S, Patella V, Pham-Thi N, Puggioni F, Ventura MT, Joos G, Kuna P, Louis R, Makris M, Zalud P, Zuberbier T, Bachert C, Brussino L, Carreiro-Martins P, Carrion Y Ribas C, Chalubinski M, Costa EM, de Vries G, Gemicioglu B, Gennimata D, Micheli Y, Niedoszytko M, Regateiro FS, Romantowski J, Taborda-Barata L, Toppila-Salmi S, Tsiligianni I, Viart F, Laune D. Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report. J Thorac Dis. 2021 May;13(5):3215-3225. doi: 10.21037/jtd-21-792. PMID: 34164213; PMCID: PMC8182538.
Copy Download .nbib Format: NLM
Gas-Particle Partitioning and SOA Yields of Organonitrate Products from NO.

ACS earth & space chemistry

Brownwood B, Turdziladze A, Hohaus T, Wu R, Mentel TF, Carlsson PTM, Tsiligiannis E, Hallquist M, Andres S, Hantschke L, Reimer D, Rohrer F, Tillmann R, Winter B, Liebmann J, Brown SS, Kiendler-Scharr A, Novelli A, Fuchs H, Fry JL.
PMID: 33889791
ACS Earth Space Chem. 2021 Apr 15;5(4):785-800. doi: 10.1021/acsearthspacechem.0c00311. Epub 2021 Mar 11.

Alkyl nitrate (AN) and secondary organic aerosol (SOA) from the reaction of nitrate radicals (NO

Cite
Brownwood B, Turdziladze A, Hohaus T, et al. Gas-Particle Partitioning and SOA Yields of Organonitrate Products from NO. ACS Earth Space Chem. 2021;5(4):785-800doi: 10.1021/acsearthspacechem.0c00311.
Brownwood, B., Turdziladze, A., Hohaus, T., Wu, R., Mentel, T. F., Carlsson, P. T. M., Tsiligiannis, E., Hallquist, M., Andres, S., Hantschke, L., Reimer, D., Rohrer, F., Tillmann, R., Winter, B., Liebmann, J., Brown, S. S., Kiendler-Scharr, A., Novelli, A., Fuchs, H., & Fry, J. L. (2021). Gas-Particle Partitioning and SOA Yields of Organonitrate Products from NO. ACS earth & space chemistry, 5(4), 785-800. https://doi.org/10.1021/acsearthspacechem.0c00311
Brownwood, Bellamy, et al. "Gas-Particle Partitioning and SOA Yields of Organonitrate Products from NO." ACS earth & space chemistry vol. 5,4 (2021): 785-800. doi: https://doi.org/10.1021/acsearthspacechem.0c00311
Brownwood B, Turdziladze A, Hohaus T, Wu R, Mentel TF, Carlsson PTM, Tsiligiannis E, Hallquist M, Andres S, Hantschke L, Reimer D, Rohrer F, Tillmann R, Winter B, Liebmann J, Brown SS, Kiendler-Scharr A, Novelli A, Fuchs H, Fry JL. Gas-Particle Partitioning and SOA Yields of Organonitrate Products from NO. ACS Earth Space Chem. 2021 Apr 15;5(4):785-800. doi: 10.1021/acsearthspacechem.0c00311. Epub 2021 Mar 11. PMID: 33889791; PMCID: PMC8054245.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 58 entries